Ocular Therapeutix
OCUL
#5701
Rank
A$1.92 B
Marketcap
A$8.77
Share price
-1.35%
Change (1 day)
-52.96%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -A$0.45 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are A$52.05 Million. In 2025 the company made an earning of -A$0.4 Billion a decrease over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.45 Billion11.43%
2025 -A$0.4 Billion37.43%
2024 -A$0.29 Billion139.68%
2023 -A$0.13 Billion13.65%
2022 -A$0.11 Billion984.05%
2021 -A$9.81 Million-95.79%
2020 -A$0.24 Billion80.19%
2019 -A$0.13 Billion44.01%
2018 -A$89.77 Million-5.38%
2017 -A$94.87 Million41.79%
2016 -A$66.91 Million12.47%
2015 -A$59.49 Million38.75%
2014 -A$42.88 Million115.12%
2013 -A$19.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-A$16.78 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-A$7.67 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-A$0.25 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.26 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA